Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ocular damage in patients with psoriasis treated by psoralen UV-A therapy or narrow band UVB therapy: a systematic literature review.
Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. Archier E, et al. Among authors: castela e. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:32-5. doi: 10.1111/j.1468-3083.2012.04521.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22512678 Review. No abstract available.
Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. Archier E, et al. Among authors: castela e. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:11-21. doi: 10.1111/j.1468-3083.2012.04519.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22512676 Review.
Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. Archier E, et al. Among authors: castela e. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:22-31. doi: 10.1111/j.1468-3083.2012.04520.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22512677 Review.
Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists.
Paul C, Gallini A, Archier E, Castela E, Devaux S, Aractingi S, Aubin F, Bachelez H, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Richard MA, Ortonne JP. Paul C, et al. Among authors: castela e. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:1-10. doi: 10.1111/j.1468-3083.2012.04518.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22512675 Review.
Blue pseudochromhidrosis secondary to topiramate treatment.
Castela E, Thomas P, Bronsard V, Lacour JP, Ortonne JP, Passeron T. Castela E, et al. Acta Derm Venereol. 2009;89(5):538-9. doi: 10.2340/00015555-0696. Acta Derm Venereol. 2009. PMID: 19734991 Free article. No abstract available.
Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial.
Boukari F, Jourdan E, Fontas E, Montaudié H, Castela E, Lacour JP, Passeron T. Boukari F, et al. Among authors: castela e. J Am Acad Dermatol. 2015 Jan;72(1):189-90.e1. doi: 10.1016/j.jaad.2014.08.023. Epub 2014 Oct 22. J Am Acad Dermatol. 2015. PMID: 25443629 Clinical Trial. No abstract available.
60 results